English-language podcasts

Equity Mates Investing Podcast

Our Monthly Portfolio Update - October 2026

35 min

Listen through the publisher, then discuss the episode here or arrange an in-person Roundtable. Your city determines where to meet.

Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.

October was a rough month for growth investors, but not every stock got the memo. Bryce & Ren unpack their latest portfolio performance, from big wins in Eli Lilly, Spotify and Pro Medicus to painful drawdowns in Alphabet, TransMedics and Asian tech. They dig into Google's slowing search growth, the future of weight-loss drugs, and a leaked CEO memo that has Ren questioning his investment in Sea Limited. In this episode: 00:00 October's market wrap: Rate hikes, AI wobbles & global returns 07:19 Portfolio updates: The winners, losers & performance 12:46 Intuitive Surgical: Why Bryce is still buying 13:57 Rule Breaker Investing: Finding great companies 19:27 Alphabet: Is Google's search business in trouble? 22:44 Spotify & Eli Lilly: Growth, GLP-1s & what comes next 27:56 Sea Limited: The leaked memo that has Ren questioning his investment 30:03 Grab & Shopify: Two growth stories worth watching Stocks & ETFs Mentioned: Alphabet (NASDAQ: GOOGL), Amazon (NASDAQ: AMZN), Microsoft (NASDAQ: MSFT), Meta Platforms (NASDAQ: META), NVIDIA (NASDAQ: NVDA), Eli Lilly (NYSE: LLY), Spotify (NYSE: SPOT), Pro Medicus (ASX: PME), Berkshire Hathaway (NYSE: BRK.B), TransMedics (NASDAQ: TMDX), Sea Limited (NYSE: SE), Intuitive Surgical (NASDAQ: ISRG), Hims & Hers Health (NYSE: HIMS), Macquarie Group (ASX: MQG), Taiwan Semiconductor Manufacturing Company (NYSE: TSM), SK Hynix (KRX: 000660), Samsung Electronics (KRX: 005930), Shopify (NASDAQ: SHOP), Grab Holdings (NASDAQ: GRAB), Novo Nordisk (NYSE: NVO), CoreWeave (NASDAQ: CRWV), Uber Technologies (NYSE: UBER) Get started with Sharesight (https://www.sharesight.com/au/equitymates/) and save 4 months on an annual paid plan: https://www.sharesight.com/equitymates ——— Want to get involved in the podcast? ——— Want more Equity Mates? Watch on YouTube (https://tinyurl.com/yc596wem) Read the monthly email (https://basispoints.beehiiv.com/) ——— Looking for some of our favourite research tools? ——— If unsure, speak to a financial professional. Hosted on Acast.

Episode information is provided by the publisher. Listening takes place on the publisher’s service.

Listen at the source ↗

Featured places to meet in Palo Alto, CA

Explore these places and arrange a conversation through ThinkMatch.

City guide for Palo Alto, CA

More from Equity Mates Investing Podcast

Equity Mates Investing Podcast

Chips, power & who gets paid in the AI build-out with William Taylor

37 min

Firmus pulled its float, NEXTDC fell more than 40% in a day, and investors are starting to question the data centre trade. Yet the hyperscalers are still spending at a scale that dwarfs the Apollo program. Ren sits down with Will Taylor, portfolio manager at ETF Shares, to unpack whether we’re in a bubble, why roughly half of every AI dollar never goes into a chip, and how the scramble for power and cooling is shaping the opportunity for long-term investors. In this episode: 00:00 Introduction 03:01 A rocky month for AI infrastructure 05:29 Trillions in hyperscaler spending 09:49 Australia’s place in the data centre story 11:41 Are we in an AI bubble? 16:04 Neoclouds and circular financing 17:40 Inside a data centre: power and cooling 24:08 Where every $100 of AI capex goes, and why not chips 27:06 The lesser-known companies behind the racks 29:30 The bottlenecks slowing the build-out 31:12 ETFs, stocks or the hyperscalers? 33:31 Are we too late? Stocks & ETFs mentioned: ETF Shares Glo

Discuss this episode

Equity Mates Investing Podcast

Did gold stop working, Anthropic’s IPO explained & Pimp my Portfolio with Luke Laretive

44 min

Gold is meant to protect you from inflation. So why has it crashed more than 30% while inflation keeps climbing? Bryce & Ren unpack what's going wrong for the world's favourite safe haven, before diving into Novo Nordisk's controversial weight-loss drug trials involving children. Then it's the IPO everyone's talking about: Anthropic is heading to the NASDAQ at a staggering $1.4 trillion valuation. Is it a generational investment opportunity, or should investors wait for the hype to settle? Plus, Luke Laretive returns for Pimp My Portfolio, helping one investor rethink an 80% allocation to just two mining stocks. In this episode: 00:00 Gold, Anthropic & what's coming up 03:16 Gold crashes 31%: Is the inflation hedge broken? 09:07 Ozempic for kids? Inside Novo Nordisk's obesity trials 14:42 Should you buy Anthropic at IPO? 16:56 Anthropic's financials & the SpaceX comparison 22:07 Why investors should think twice before buying an IPO 25:38 When will Anthropic enter the US indexes? 29:30

Discuss this episode

Equity Mates Investing Podcast

“Everyone is always wrong” - What Luke Laretive learned from a tough year in small caps

43 min

After a strong first three years for Seneca’s Australian Small Companies Fund, Luke Laretive returns to share what he has learned from managing through a difficult small-cap market. We also discuss the small-cap outlook, the M&A cycle, Antipa and Greatland, and why Luke sees value in fund managers. In this episode: 00:00 Luke Laretive Returns 03:03 Lessons From Three Years 04:22 Be Flexible With Investments 09:22 Finding Special Situations 11:06 Learning From Investment Losses 14:24 Small Caps And The Outlook 19:10 Recency Bias And M&A 23:20 How Index Investing Works 25:06 The Antipa Takeover Thesis 29:37 The Case For Fund Managers 37:20 Platforms And Market Sentiment 40:40 Closing Thoughts Stocks mentioned: Euroz Hartleys Group (ASX: EZL), Venus Metals Corporation (ASX: VMC), Matsa Resources (ASX: MAT), Antipa Minerals (ASX: AZY), Greatland Resources (ASX: GGP), Regal Partners (ASX: RPL), GQG Partners (ASX: GQG), L1 Group (ASX: L1G), Pinnacle Investment Management Group (ASX: PNI), HU

Discuss this episode

Community Poll

Platforms should prioritize preventing harassment even when this limits some expression.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer

Common Quandary

A Common Quandary to discuss

Another conversation to explore, separate from this news story.

You are training the software that may replace your team. Do you warn them?

A manager is asked to help test software that could eliminate several jobs on their team. Leadership insists the project is uncertain and confidential, while employees are making major financial decisions.

When does loyalty to colleagues override professional confidentiality?

Explore this quandary